Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4465352
Max Phase: Preclinical
Molecular Formula: C18H19FN4
Molecular Weight: 310.38
Molecule Type: Unknown
Associated Items:
ID: ALA4465352
Max Phase: Preclinical
Molecular Formula: C18H19FN4
Molecular Weight: 310.38
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(C)c1ccc(NCc2c[nH]nc2-c2ccc(F)cc2)cc1
Standard InChI: InChI=1S/C18H19FN4/c1-23(2)17-9-7-16(8-10-17)20-11-14-12-21-22-18(14)13-3-5-15(19)6-4-13/h3-10,12,20H,11H2,1-2H3,(H,21,22)
Standard InChI Key: JCZIUZBVBPQRJX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 310.38 | Molecular Weight (Monoisotopic): 310.1594 | AlogP: 3.89 | #Rotatable Bonds: 5 |
Polar Surface Area: 43.95 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 6.64 | CX LogP: 3.76 | CX LogD: 3.69 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.75 | Np Likeness Score: -1.98 |
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |
Source(1):